الفهرس | Only 14 pages are availabe for public view |
Abstract Sepsis is a systemic inflammatory response (SIRS) of the host to several infections. It can lead to severe sepsis which remains a principle cause of death in Intensive Care Units (ICU) worldwide, with one in four patients dying of severe sepsis or septic shock . Early recognition of sepsis is not always straightforward and clinical signs at presentation can be misleading and very heterogeneous due to frequent comorbidities. In the emergency setting therefore an urgent need for a reliable diagnostic procedure, allowing early discrimination between SIRS and sepsis, is mandatory. Biomarkers, such as C-reactive protein (CRP) and procalcitonin (PCT), introduced among the diagnostic criteria of sepsis could contribute to promptly identify patients affected by sepsis, severe sepsis and septic shock who could benefit from quick and appropriate therapy. Procalcitonin (PCT) and C-reactive protein (CRP) are the most frequently used biomarkers in sepsis. Of the many studied biomarkers, procalcitonin remains the gold standard for sepsis diagnosis, and is considered to be an indicator of the severity of clinical sepsis. |